Skip to main content

Cyclist Receives Sanction

Cyclist Receives Sanction

Sport Integrity Australia acknowledges the decision of AusCycling to impose a three-year ban on athlete Jackson Sharples for the Presence, Use, Use and/or Attempted Use, and Possession of Prohibited Substances.

Mr Sharples returned Adverse Analytical Findings (AAF) from an In-Competition doping control test during the National Road Cycling Championships Masters Criterium on 14 January 2022.

His sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, which detected the presence of Anastrozole and its metabolite OH-Anastrozole, and Exogenous Testosterone and its metabolites Etiocholanolone, Androsterone and 5βAdiol.

It was also determined that on and/or before 14 January 2022, Mr Sharples used Anastrozole and Testosterone.

In addition, it was also determined:

  • Between 16 August 2021 and 31 December 2021, Mr Sharples used and/or attempted to use Ipamorelin and/or DHEA.
  • Between 16 August 2021 and 31 December 2021, Mr Sharples possessed Testosterone and/or Anastrozole and/or Ipamorelin and/or DHEA.

Mr Sharples is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 31 December 2024.

 

ADDITIONAL INFORMATION ON THE PROHIBITED SUBSTANCE  

Under category S1 of the World Anti-Doping Code Prohibited List, Testosterone and Dehydroepiandrosterone (DHEA) are anabolic agents prohibited both in-and out-of-competition.

Anabolic agents pose many threats to an athlete’s health and some side effects may include an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease and infertility can also result from the use of these agents.

The substance Anastrozole is a class S4.1 substance under the World Anti-Doping Code Prohibited List 2021. Anastrozole is classified as a Specified Substance and is prohibited at all times.

Anastrozole is a hormone and metabolic modulator prescribed to treat early breast cancer.

As the use of hormone and metabolic modulators interferes with the normal functioning nature of hormones, the endocrine system that controls these hormones is significantly impacted. This interferes can therefore increases the risk of severe illnesses.

Ipamorelin is a selective growth hormone for weight loss and is listed as a class S2.2 substance under the WADA Prohibited List. It is prohibited at all times.

Leave a comment

Please login to leave a comment.

Upcoming Events